UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGIC ...

Hologic, Inc. (NASDAQ:HOLX) Q2 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tim Daley - Wells Fargo Casey Woodring - JPMorgan Anthony Petrone - Mizuho Group Elizabeth Garcia - UBS Andrew Cooper - Raymond James Jack Meehan - Nephron Research Puneet Souda - SVB Securities Jack Meehan - Nephron Research Max Masucci - Cowen & Company Tejas Sa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGI ...

Hologic, Inc. (NASDAQ:HOLX) Q1 2023 Earnings Conference Call February 1, 2023 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Max Masucci - Cowen & Company Puneet Souda - SVB Securities Vijay Kumar - Evercore ISI Tim Daley - Wells Fargo Tejas Savant - Morgan Stanley Derik de Bruin - Bank of America Dustin Scaringe - William Blair Navann Ty - BNP Pariba ...

Millions • 14.7% constant currency organic Strong Balance Sheet for Future Capital Deployment Opportunities • No near-term debt maturities, no balance outstanding on revolver 25 *Net debt is total debt minus cash in $ billions; leverage ratio is principal debt minus cash to TTM adjusted EBITDA Introduction Results Driven 26 • Purpose Driven, Results Driven ...with Leadership Across the Continuum of Care SUP 23 24 • Stability in NovaSure Non-COVID Panther Utilization Metrics • Panther non-COVID utilization g ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HO ...

3 Introduction Elevating Global Women's Health… • 4th for large companies in San Diego County by The San Diego Union-Tribune 2 Non-GAAP Financial Measures The Company has presented the following non-GAAP financial measures in this presentation: constant currency revenues; organic revenues; non-GAAP gross margin; non-GAAP operating expenses; non-GAAP operating margin; non-GAAP effective tax rate; non-GAAP net income; non-GAAP net margin; non-GAAP EPS; and adjusted EBITDA. Constant currency calculations show ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 24, 2022 or For the transition period from to Commission File Number: 1-36214 __________________________________________________________ Securities registered pursuant to Section 12(b) of the Act: HOLOGIC, INC. (Exact ...

Hologic, Inc. (NASDAQ:HOLX) Q4 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Anthony Petrone - Mizuho Group Jack Meehan - Nephron Research Puneet Souda - SVB Securities Liza Garcia - UBS Max Masucci - Cowen and Company Tim Daley - Wells Fargo Derik de Bruin - Bank of America Casey Woodring - JPMorgan Oper ...

Hologic, Inc. (NASDAQ:HOLX) Q3 2022 Results Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Patrick Donnelly - Citigroup Nisarg Shah - Bank of America Merrill Lynch Vijay Kumar - Evercore ISI Joseph Conway - Needham & Company Puneet Souda - ...